Coronary heart disease
Cardium Therapeutics, Inc. today announced its acquisition of the wound healing technology and related assets of the Tissue Repair Company , a privately-held, San Diego-based company focused on the development of growth factor therapeutics for the potential treatment of tissue wounds such as dermal ulcers, which affect millions of diabetic patients.
Source: biz.yahoo.com
American College of Cardiology/American Heart Association/European Society of Cardiology Scientific Statement:
Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation , according to revised Guidelines for the Management of Patients with Atrial Fibrillation released today by the American College of Cardiology, American Heart Association and the European Society of Cardiology.
Source: biz.yahoo.com
Blood Clots Can Be Treated By Injections At Home
Treatment of blood clots in the deep veins of the legs or the lungs with an older, less expensive form of the anticoagulant medication heparin can be just as safe and effective as similar treatment with a newer and more expensive heparin.
Source: www.sciencedaily.com
Oxygen Deprived Brains Repaired And Saved
Scientists from Melbourne’s Howard Florey Institute have found special proteins that protect the brain after it has been damaged by a lack of oxygen, which occurs in conditions such as stroke, perinatal asphyxia, near-drowning and traumatic brain injury.
Source: www.sciencedaily.com
Cytori Announces 2nd Quarter Results; Reports Cardiovascular Clinical Development Plans
Cytori Therapeutics, Inc. (NASDAQ:CYTX)(Frankfurt:XMPA) today announced financial results for the quarter ended June 30, 2006 and outlined plans for its upcoming clinical trials of adipose-derived stem and regenerative cells (ADRC) for cardiovascular indications in Europe.
Source: www.redorbit.com
Tags: Heart Disease
